Commerzbank Aktiengesellschaft FI Has $1.79 Million Stock Position in Cardinal Health, Inc. (NYSE:CAH)

Commerzbank Aktiengesellschaft FI increased its position in Cardinal Health, Inc. (NYSE:CAH) by 53.3% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 15,136 shares of the company’s stock after purchasing an additional 5,260 shares during the quarter. Commerzbank Aktiengesellschaft FI’s holdings in Cardinal Health were worth $1,785,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Rothschild Investment LLC grew its stake in Cardinal Health by 10.1% in the fourth quarter. Rothschild Investment LLC now owns 858 shares of the company’s stock valued at $101,000 after acquiring an additional 79 shares during the period. Private Trust Co. NA lifted its holdings in shares of Cardinal Health by 11.0% in the 4th quarter. Private Trust Co. NA now owns 930 shares of the company’s stock worth $110,000 after purchasing an additional 92 shares in the last quarter. Checchi Capital Advisers LLC grew its position in Cardinal Health by 2.7% in the 4th quarter. Checchi Capital Advisers LLC now owns 3,479 shares of the company’s stock valued at $411,000 after purchasing an additional 93 shares during the period. MWA Asset Management increased its stake in Cardinal Health by 2.9% during the 4th quarter. MWA Asset Management now owns 3,324 shares of the company’s stock valued at $393,000 after purchasing an additional 95 shares in the last quarter. Finally, Transcend Capital Advisors LLC raised its holdings in Cardinal Health by 3.6% during the fourth quarter. Transcend Capital Advisors LLC now owns 2,735 shares of the company’s stock worth $323,000 after buying an additional 96 shares during the last quarter. 87.17% of the stock is owned by institutional investors.

Cardinal Health Stock Performance

Shares of NYSE:CAH opened at $128.96 on Tuesday. Cardinal Health, Inc. has a fifty-two week low of $93.17 and a fifty-two week high of $132.84. The company’s 50-day moving average is $124.96 and its 200 day moving average is $118.40. The company has a market capitalization of $31.15 billion, a P/E ratio of 24.06, a price-to-earnings-growth ratio of 1.49 and a beta of 0.63.

Cardinal Health (NYSE:CAH) last released its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, beating analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. As a group, research analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be given a $0.5056 dividend. This represents a $2.02 dividend on an annualized basis and a yield of 1.57%. The ex-dividend date is Tuesday, April 1st. Cardinal Health’s dividend payout ratio is currently 37.69%.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on CAH. TD Cowen upgraded shares of Cardinal Health from a “hold” rating to a “buy” rating and lifted their price objective for the company from $130.00 to $144.00 in a report on Wednesday, January 8th. Wells Fargo & Company lifted their price target on Cardinal Health from $135.00 to $136.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 4th. UBS Group increased their price objective on Cardinal Health from $134.00 to $139.00 and gave the stock a “buy” rating in a research note on Monday, November 4th. Evercore ISI upgraded Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 target price on the stock in a report on Tuesday, January 7th. Finally, Barclays upped their price target on Cardinal Health from $117.00 to $133.00 and gave the stock an “overweight” rating in a report on Monday, November 4th. Four investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $139.36.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.